Clinical Trial Update: Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation [Phase 2]

View source ↗

Summary

Phase 2 trial of YKP10811 in irritable bowel syndrome with constipation has completed, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Irritable Bowel Syndrome

Drugs mentioned

• YKP10811

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Irritable Bowel Syndrome, Constipation | Phase 2 | Status: COMPLETED